Ask1 deletion may attenuate this suppression and compensate for MPP+-mediated dopamine deficits, thus suggesting that restoring dopamine/acetylcholine balance could be a potential therapeutic approach for dopaminergic toxicity and Parkinson’s disease. The gene discussed is MAP3K5; the disease is Parkinson disease.